CardioGard received a 510(K) clearance for its Emboli Protection Cannula

We are pleased to announce that CardioGard, a Peregrine Ventures portfolio company, has received a 510(K) clearance for its Emboli protection cannula, and the device can now be imported into and marketed in the United States.

CardioGard is developing a specially designed arterial (aortic) cannula for use in cardiac surgery for the purpose of removal of gaseous and solid embolic material emanating from aortic manipulations. The cannula comprises a double lumen where the primary lumen provides oxygenated blood from the heart-lung machine to the patient and a secondary lumen suctions blood and embolic matter away from the surgical field and back to the cardiopulmonary bypass machine for filtration.

Recent Posts
Featured Posts
Follow Us
Search By Tags
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square